$LEVI

Peter E. Haas Jr. Family Fund sold $3.5M of LEVI

Peter E. Haas Jr. Family Fund sold 145,662 shares of LEVI STRAUSS & CO (LEVI) at $24.01 ($3.50M total) on 2026-06-11 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · Peter E. Haas Jr. Family Fund
Published Jun 12, 2026, 9:04 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jun 12, 2026, 9:09 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$LEVI
Neutral
medium confidence
Mentioned
$LEVI
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$LEVINeutralLow
01

Why it matters

A 10% owner selling down to zero can attract attention from short-term traders, but the 10b5-1 designation reduces interpretability as a new negative thesis.

02

Market read

Concrete insider sale details ($3.5M value; executed 2026-06-11) provide a fresh positioning datapoint, but no new business/earnings/regulatory catalyst is included.

03

What to watch

The article doesn’t state whether other insiders or institutions changed positions around the same time; without that, the signal is mostly sentiment/positioning rather than a fundamental read-through.

Relevance 5/10Novelty 8/10Timing: Filed 2026-06-12; sale executed 2026-06-11

Background

This is an SEC Form 4 insider transaction disclosure for LEVI, reported via EDGAR.

Company-level read

Ticker impact

$LEVINeutralMedium confidence
Context

Peter E. Haas Jr. Family Fund (10% owner) filed an open-market sale of 145,662 LEVI shares at $24.0084 on 2026-06-11, leaving 0 shares.

Expected impact

Likely limited/short-lived impact; any effect should be more sentiment-driven than fundamental.

Evidence & confidence

Form 4 provides a concrete ownership change and size (~$3.5M), but the article specifies a pre-arranged 10b5-1 plan and contains no company-specific operational or financial catalyst.

Market effects

Minimal; this is company-specific insider activity with no sector-wide signal.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect liquidity/tax planning rather than bearish expectations.

Key entities

  • LEVI STRAUSS & CO

    The publicly traded company whose shares were sold.

  • Peter E. Haas Jr. Family Fund

    The reporting insider entity executing the open-market sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$LEVIHighAI 8/10

Levi's CEO admits the company missed the biggest jeans trend of the year

Levi Strauss & Co. (LEVI) CEO Michelle Gass admitted the company missed the U.S. shift to low-rise jeans during the back-to-school season, impacting its direct-to-consumer sales. Despite a 4% revenue increase to $1.6 billion in Q3, shares fell nearly 5%. Levi's has since refocused marketing on low-rise styles and expects full-year revenue growth of about 6%.

$LEVIMed

Levi Strauss CEO Sounds Alarm on Growing Competition in Denim Market

Levi Strauss reported mixed results: European revenue rose 4-5%, Asia saw 5-10% growth, and Signature brand revenue jumped 13%. The company raised its adjusted earnings forecast to $1.54-$1.56 per share but lowered its revenue growth outlook to ~7%. CEO Michelle Gass noted increased competition in the denim market, emphasizing the need for innovation to maintain market share.

$LEVIMed

BNP Paribas Exane raises Levi Strauss price target to $35

BNP Paribas Exane raised its price target for Levi Strauss (LEVI) to $35, citing strong revenue growth and margins. The company reported Q3 revenue of $1.6B, up 4.3%, and EPS of $0.48, beating some estimates. Analysts note challenges in direct-to-consumer sales but see long-term growth potential. Other firms adjusted targets, ranging from $22 to $27.